73
Peptide profiles
75
Compounds compared
252
Verified discount codes
100%
Independent research
4,393
Prices compared
Certificates lab-checked in the last 7 days, as of November 20, 2026: Inno Aminos, ORA Aminos, Recherche Logistique and 1 more.
Prof. Peptide provides peptide research for educational purposes only. Nothing on this site constitutes medical advice or endorses human use of research peptides.
Everything a researcher needs
From peptide mechanisms to reconstitution math — Prof. Peptide covers it all, clearly and credibly.
Peptide Library
Comprehensive profiles on 73 research peptides — mechanisms, half-lives, stacking protocols, and more.
Browse library →Bioregulator Guide
A research guide to the Khavinson short-peptide bioregulators — the gene-regulation hypothesis, synthetic analogs vs. organ extracts, and the individual compounds.
Read the guide →Comparisons
Side-by-side breakdowns of popular peptides and supplements — mechanisms, evidence, dosing, and how to choose between them.
Compare compounds →Featured Vendors
The vetted alphabetical list of research peptide suppliers — with third-party testing, published COAs, and the quality criteria Prof. Peptide uses to include them.
See vetted vendors →Prices
Compare research-peptide prices across 252 vendors — normalized to $/mg by vial size, post-code, and sorted lowest-first.
Compare prices →Coupon Codes
Verified discount codes for research-grade suppliers. Updated regularly.
See codes →Peptide Reconstitution & Dosage Calculator
Accurately reconstitute and dose any peptide with our step-by-step research calculator.
Open calculator →Get the App
The all-in-one peptide tracker for iPhone — log doses, see estimated levels, run protocols, and search 70+ peptides by name or brand.
Download →News
The latest peptide research news, regulatory updates, and developments.
View news →Latest News
View all newsNovember 19, 2026
Thymosin Beta-4 Eye Drop RGN-259 Misses Its Primary Endpoint in a Third Phase 3 Trial
SEER-2, a phase 3 trial of RGN-259 (thymosin beta-4 eye drops) for neurotrophic keratopathy at 50 sites, did not reach statistical significance on complete healing at 4 weeks, its sponsor reported in November 2026; no rates are published yet. None of the eye drop's three phase 3 trials has met its primary endpoint, and the results say nothing about injected TB-500.
Read more →November 16, 2026
COURAGE Trial: A Myostatin Antibody Preserved Lean Mass on Semaglutide
COURAGE (The Lancet, November 11, 2026), phase 2, 975 adults with obesity on semaglutide 2.4 mg: trevogrumab, an investigational antibody that blocks myostatin, cut lean-mass loss by up to 3.1 points against placebo. Adding garetosmab kept more lean mass but brought 9% serious adverse events, 32% discontinuations and two deaths. It is not follistatin, and neither antibody is approved.
Read more →November 16, 2026
Health Canada Finds Bacteria in a Seized Injectable Peptide in Ottawa
Health Canada's November 12, 2026 advisory: lab testing found Sphingomonas bacteria in an injectable peptide product seized from Sage & Summit Wellness Co. in Ottawa, whose unauthorized vials were labelled BPC-157, KLOW, MOTS-c, Semax, retatrutide and more, some 'For Research Purposes Only'. The advisory does not say which product was contaminated.
Read more →Built for researchers
Most peptide sites exist to sell products. Prof. Peptide exists to educate. We're independent, ad-light, and committed to presenting research accurately — including limitations and unknowns.
- ✓Content is editorially independent and research-driven
- ✓Every peptide profile cites primary research literature
- ✓Calculator math is transparent and peer-reviewable
- ✓Discount codes are manually verified before publishing
Now on iOS
The all-in-one peptide tracker
Log doses, see estimated levels, calculate reconstitution, and search 70+ peptides by name or brand — all in one private iOS app.
Get the AppDon't overpay for peptides.
Prof. Peptide finds the best deals and delivers them to your inbox.

